Wednesday, Sen. Bernie Sanders (I-VT), chairman of the Senate’s Health, Education, Labor and Pensions Committee, sent a letter to Sanofi and Novo Nordisk urging them to lower insulin prices.
https://www.pharmalive.com/wp-content/uploads/2023/03/BioSpaceBernie3-3-2023.jpg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2023-03-03 08:00:102023-03-03 10:21:18Sanders calls on Sanofi, Novo to follow Lilly in cutting insulin prices
